Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TQG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,736
Award facts
- Contract value 100% obligated
- $13,735.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13.7K delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Gemtesa 75 mg tablets (90-count units) with completion required by January 15, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. That primary IDC, valued at up to $999.9 million through December 2031, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, functions as a critical vendor in the federal medical procurement supply chain and has demonstrated capability to fulfill government pharmaceutical requirements through open competition. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency and other agencies reflects its role as a major pharmaceutical distributor supporting military treatment facilities, veteran healthcare programs, and other federal medical institutions. This delivery order for Gemtesa, a medication used in urology, exemplifies the diverse therapeutic categories covered under the broader IDC vehicle and the company's ability to execute small to large value pharmaceutical deliveries efficiently.
Quick answers
Who was awarded contract SPE2DR26F3TQG?
SPE2DR26F3TQG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F3TQG worth?
The government has obligated $13,736 on SPE2DR26F3TQG.
Is contract SPE2DR26F3TQG an order under another contract?
Yes. SPE2DR26F3TQG is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TQG competed?
The extent of competition for SPE2DR26F3TQG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award